Zhuhai Rundu Pharmaceutical Co., Ltd. engages in the manufacture, research and development, and marketing of pharmaceutical drugs. Its products include valsartan, irbesartan, candesartan cilexetil, olmesartan medoxomil, piperaquine phosphate, voriconazole, lansoprazole, rabeprazole sodium, dasatinib, and gefitinib. The company was founded on December 30, 1999 and is headquartered in Zhuhai, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company